Hyperleptinemia - Non-Haemodynamic Risk Factor for the Left Ventricular Hypertrophy Development in Hypertensive Overweight Females

被引:0
|
作者
Selthofer-Relatic, Kristina [1 ]
Radic, Radivoje [3 ]
Vizjak, Vedrana [1 ]
Vcev, Aleksandar [1 ]
Kosovic, Pasezada [2 ]
Bosnjak, Ivica [1 ]
Selthofer, Robert [3 ]
机构
[1] Univ Hosp Osijek, Clin Internal Med, Osijek, Croatia
[2] Univ Hosp Osijek, Dept Nucl Med, Osijek, Croatia
[3] Univ JJ Strossmayer, Fac Med, Dept Anat, Osijek, Croatia
关键词
leptin; obesity; hypertension; left ventricular hypertrophy;
D O I
暂无
中图分类号
Q98 [人类学];
学科分类号
030303 ;
摘要
Obesity is directly and strongly associated with hypertension and left ventricular hypertrophy (LVH). Development of LVH is multifactorial, caused both by haemodynamic and non-haemodynamic factors. Hypertension is the main haemodynamic factor. Humoral mechanisms, as a non-haemodynamic factor for LVH development, have not been completely explained. The aim of this study is to determine whether hyperleptinemia can be one of humoral - non-haemodynamic factor inducing LVH together with haemodynamic factors in overweight females. The study was done on thirty six adult, overweight female patients, body mass index in range 25-30 kg/m(2). Patients are nondiabetic with regular renal function. Twenty one female patients were hypertensive with left ventricular hypertrophy. Control group included fifteen hypertensive female patients without left ventricular hypertrophy. In all patients was determined glucose profile and creatinine clearance, cholesterol, triglycerides, LDL, HDL. Weight, high, circumference of the waist and hips was taken. Cardiovascular determination was done applying two-dimensional ultrasound. Serum leptin level was measured using radioimmunoassay method (RIA). Results showed that serum leptin level was significantly higher in hypertensive, overweight females with LVH. This suggests that non-haemodynamic factors, such as hyperleptinemia, participate in left ventricular hypertrophy development together with haemodynamic factors in adult hypertonic, overweight females.
引用
收藏
页码:681 / 685
页数:5
相关论文
共 50 条
  • [31] ASSOCIATION OF CARDIOVASCULAR RISK-FACTORS IN HYPERTENSIVE PATIENTS WITH LEFT-VENTRICULAR HYPERTROPHY
    LAVIADES, C
    MAYOR, G
    DIEZ, J
    REVISTA CLINICA ESPANOLA, 1991, 189 (09): : 403 - 407
  • [32] Prediction of carotid plaques in hypertensive patients by risk factors, left ventricular hypertrophy, and epicardial adipose tissue thickness
    Sante D. Pierdomenico
    Mariantonietta Mancini
    Chiara Cuccurullo
    Maria D. Guglielmi
    Anna M. Pierdomenico
    Marta Di Nicola
    Silvio Di Carlo
    Domenico Lapenna
    Franco Cuccurullo
    Heart and Vessels, 2013, 28 : 277 - 283
  • [33] Prediction of carotid plaques in hypertensive patients by risk factors, left ventricular hypertrophy, and epicardial adipose tissue thickness
    Pierdomenico, Sante D.
    Mancini, Mariantonietta
    Cuccurullo, Chiara
    Guglielmi, Maria D.
    Pierdomenico, Anna M.
    Di Nicola, Marta
    Di Carlo, Silvio
    Lapenna, Domenico
    Cuccurullo, Franco
    HEART AND VESSELS, 2013, 28 (03) : 277 - 283
  • [34] VALUE OF THE NON HEMODYNAMIC PARAMETERS IN THE DEVELOPMENT OF LEFT VENTRICULAR HYPERTROPHY IN HYPERTENSION
    Piskorz, Daniel
    Quaglino, Marta
    Pigozzi, Fernanda
    Vitelleschi, Maria
    REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2010, 39 (04): : 288 - 293
  • [35] Relationship of left ventricular systolic function to persistence or development of electrocardiographic left ventricular hypertrophy in hypertensive patients: implications for the development of new heart failure
    Okin, Peter M.
    Wachtell, Kristian
    Gerdts, Eva
    Dahlof, Bjorn
    Devereux, Richard B.
    JOURNAL OF HYPERTENSION, 2014, 32 (12) : 2472 - 2478
  • [36] Changes in serum and intracardiac fibroblast growth factor 23 during the progression of left ventricular hypertrophy in hypertensive model rats
    Fujii, Hideki
    Watanabe, Entaro
    Kono, Keiji
    Goto, Shunsuke
    Watana, Shuhei
    Nishi, Shinichi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2019, 23 (05) : 589 - 596
  • [37] LEFT-VENTRICULAR HYPERTROPHY AS A RISK FACTOR FOR ARRHYTHMIAS IN HEMODIALYSIS-PATIENTS
    SARAGOCA, MA
    CANZIANI, ME
    CASSIOLATO, JL
    GIL, MA
    ANDRADE, JL
    DRAIBE, SA
    MARTINEZ, EE
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 17 : S136 - S138
  • [38] Variants of tumor necrosis factor-induced protein 3 gene are associated with left ventricular hypertrophy in hypertensive patients
    Xue Hao
    Wang Shu-xia
    Wang Xiao-jian
    Xin Ying
    Wang Hu
    Song Xiao-dong
    Sun Kai
    Wang Yi-bo
    Hui Ru-tai
    CHINESE MEDICAL JOURNAL, 2011, 124 (10) : 1498 - 1503
  • [39] Changes in serum and intracardiac fibroblast growth factor 23 during the progression of left ventricular hypertrophy in hypertensive model rats
    Hideki Fujii
    Kentaro Watanabe
    Keiji Kono
    Shunsuke Goto
    Shuhei Watanabe
    Shinichi Nishi
    Clinical and Experimental Nephrology, 2019, 23 : 589 - 596
  • [40] Hypoalbuminemia as a risk factor for progressive left-ventricular hypertrophy in hemodialysis patients
    Moon, KH
    Song, IS
    Yang, WS
    Shin, YT
    Kim, SB
    Song, JK
    Park, JS
    AMERICAN JOURNAL OF NEPHROLOGY, 2000, 20 (05) : 396 - 401